Welcome to the Kidney Clinical Research Unit

An innovative facility where multidisciplinary team members conduct research in the areas of kidney health, kidney disease, treatments of dialysis, and kidney transplantation.

The Lilibeth Caberto Kidney Clinical Research Unit (KCRU) is a 4,000 square-foot facility located at Victoria Hospital, London Health Sciences Centre. Dr. Christopher McIntyre is the Director of the KCRU and Robert Lindsay Chair of Dialysis Research and Innovation. The KCRU hosts a collection of the highest quality researchers from across Canada and around the world, many of whom are enrolled in the MSc/PhD Medical Biophysics program within Western University.

60737908991__A8BDB12A-AAD6-4A50-8B61-F41
 

Kidney Clinical Research Unit Buzz

 

Is salt build-up a potential cause of heart disease in kidney disease patients?

Taylor Marcus, MSc, has launched a crowdfunding campaign to raise money for her project! The campaign is live on experiment.com. All donations will help the research team image and analyze the first few patients participants by covering the cost of MRI scan time and laboratory supplies. Click the link below to view her campaign and learn more about her project!

https://lnkd.in/eCvYgWW

Screen Shot 2021-07-23 at 5.51.00 PM.png
 

Research Philosophy

Screen Shot 2021-02-03 at 9.40.39 PM.png

Dr. Christopher McIntyre is Professor of Medicine, Professor of Medical Biophysics, Professor of Paediatrics, and Robert Lindsay Chair of Dialysis Research and Innovation at Western. He also serves as Director of the Lilibeth Caberto Kidney Clinical Research Unit (KCRU) at London Health Sciences Centre, where he is a practicing Clinical Nephrologist. Dr McIntyre was awarded the Lawson Scientist of the Year Award for 2020. He leads a team of multidisciplinary researchers who focus largely on the pathophysiology of the effecting cardiovascular, brain, liver, and gastrointestinal structure and function in patients with chronic kidney disease. These studies include basic clinical science, natural history studies, and the development and application of novel therapeutic strategies into large scale randomized controlled trials. These studies have increasingly focused on the adverse consequences resulting from dialysis therapy itself and the improvement in outcomes by the reduction of preventable harm. Multimodal imaging plays an important role in these studies including ultrasound, CT, MRI, and PET.


Research Areas of Interest: Dialysis, Applied Imaging (CT, MRI, PET), Chronic Kidney Disease, Cardio Renal Medicine 

 
 

Contact Us

800 Commissioners Rd E, London, ON N6A 5W9, Canada